Llwytho...
Engineering and Design of Chimeric Antigen Receptors
T cells engineered with chimeric antigen receptors (CARs) have emerged as a potent new class of therapeutics for cancer, based on their remarkable potency in blood cancers. Since the first clinical reports of their efficacy emerged 7 years ago, investigators have focused on the mechanisms and proper...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Mol Ther Methods Clin Dev |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society of Gene & Cell Therapy
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6330382/ https://ncbi.nlm.nih.gov/pubmed/30666307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2018.12.009 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|